ARCHIVES

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

This article is from The Cancer Letter archive.

Vol. 09 No. 33 | August 19, 1983

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Army Breast Cancer Research Program Seeks Proposals

March 28, 1997

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Diptheria Toxin Prompts Immune System To Kill Cancer

December 29, 2006

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Centers See Trend To Integrate Control Service With Science

February 18, 1983